How to treat arterial hypertension in obese patients?

Area of Science:

• Cardiology
• Metabolic Diseases
• Hypertension Research

Background:

• Obesity and arterial hypertension are prevalent, often co-occurring conditions.
• This combination significantly elevates cardiometabolic risk, including atherosclerotic vascular diseases and type 2 diabetes.
• Hypertension in obese individuals can be drug-resistant, salt-sensitive, and associated with organ damage.

Purpose of the Study:

• To explore the common pathophysiological mechanisms linking obesity and hypertension.
• To understand how these mechanisms contribute to macro- and micro-vascular complications.
• To identify optimal management strategies for hypertension in obese patients.

Main Methods:

• Review of pathophysiological mechanisms underlying obesity and hypertension.
• Analysis of factors contributing to hypertension resistance and salt sensitivity in obesity.
• Evaluation of pharmacological approaches for managing hypertension in obese populations.

Main Results:

• Shared pathophysiological pathways contribute to the development of both obesity and hypertension.
• These intertwined mechanisms drive the progression of vascular complications.
• Specific drug combinations are suggested for effective hypertension management in obesity.

Conclusions:

• Understanding shared mechanisms is crucial for managing co-existing obesity and hypertension.
• Pharmacological strategies should address the unique challenges of hypertension in obese patients.
• Combination therapy with ACE inhibitors and indapamide shows promise for treating hypertension in obesity.